Jason V Coloma sold $553K of Maze Therapeutics (MAZE)

Executed Sep 2, disclosed Sep 4, 2 days later.

Value, as filed

$553K

21,134 sh across 2 lots

Executed

Sep 2

the trade date, as filed

Disclosed

Sep 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason V Coloma Chief Executive Officer profile →

Jason V Coloma (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $908K of MAZE (30,311 sh × $29.95, as filed), executed Jul 1.

The name

MAZE

Maze Therapeutics, Inc. MAZE · Healthcare · 36 filings in 24 months ticker →

Healthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason V Coloma in MAZE

MAZESALE Maze Therapeutics, Inc. $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET MAZESALE Maze Therapeutics, Inc. $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET MAZESALE Maze Therapeutics, Inc. $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $783K
30,086 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET